-
Evaluating the Cost-Effectiveness of Wastewater-Based Disease Surveillance
Mar 10, 2025, 14:00 PM -
Disparities in Breast Cancer Screening Rates are Compounded by Type of Insurance Coverage and Social Drivers of Health
Mar 10, 2025, 14:00 PM -
Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe
Mar 10, 2025, 14:00 PM -
Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
Selection and Stability of Parametric Bivariate Copula Models for Joint Modelling of Overall and Progression-Free Survival
Mar 10, 2025, 14:00 PM -
Healthcare Resource U tilization and Healthcare Costs After Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The ENDURE Study
Mar 10, 2025, 14:00 PM -
Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Approaches to Model Patient And Carer Utilities and Disutilities of Adverse Events in Economic Models for Rare Disease Treatments in NICE Appraisals
Mar 10, 2025, 14:00 PM -
Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic
Mar 10, 2025, 14:00 PM -
Comparison of an Innovative Static Model With Dynamic Adjustment With a Dynamic Model To Assess the Public Health Impact of TAK-003 Vaccination: Case Studies in Thailand and Brazil
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management
Mar 10, 2025, 14:00 PM -
Understanding Japanese Subsidy Initiatives for Rare, Intractable Diseases
Mar 10, 2025, 14:00 PM -
Modeling the Potential Health Benefits of Improving Nutrition in Australian Indigenous Populations
Mar 10, 2025, 14:00 PM -
Epidemiological Analysis and Patient Profile of Lung Cancer in the Brazilian Public Health System: A Real-World Data Study
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns, Patient Characteristics, Healthcare Resource Utilization and Costs for Intermediate Hepatocellular Carcinoma Patients in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
Mar 10, 2025, 14:00 PM -
Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database
Mar 10, 2025, 14:00 PM -
Conceptual Mapping of Health-Related Quality of Life, Quality of Life, and Wellbeing: A Systematic Review and Assessment of Commonly Used Patient Reported Outcomes Measures
Mar 10, 2025, 14:00 PM -
Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial
Mar 10, 2025, 14:00 PM -
Leveraging Artificial Intelligence to Streamline Study Quality Assessment in Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain
Mar 10, 2025, 14:00 PM
